We think its portfolio and pipeline support a wide moat, and with the HCV market stabilizing, Gilead needs strong continued innovation in HIV, solid oncology pipeline data, and smart future ...
Gilead Sciences Inc. sees 2025 earnings rising faster than Wall Street expected after a big fourth-quarter beat highlighted ...
Operator Good afternoon, everyone, and welcome to Gilead's fourth quarter and full year 2024 earnings conference call. My ...
Investors led by Elon Musk offer $97.4 billion for OpenAI. Sam Altman replies: 'No thank you.' ...
More than 40 years after he was diagnosed with HIV, the chair of Qtopia is being remembered as "a spectacular and selfless ...
Gilead Sciences, Inc. ( NASDAQ: GILD) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ET Jacquie Ross - SVP, Treasury & IR Daniel O'Day - Chairman, CEO Johanna Mercier - Chief Commercial ...
Where would you be and what would you be doing tomorrow, February 14 , 2025 Valentine’s Day? Painting the town red or just watching the world go by?My boosts long hung and other Valentine ...
2d
Zacks.com on MSNGilead Sciences (GILD) is a Top-Ranked Momentum Stock: Should You Buy?It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Kevin McKenna, a Labour MP for Sittingbourne and Sheppey in Kent, opened up about his diagnosis during a debate in Westminster Hall yesterday, where he encouraged people to ‘just get tested’, adding: ...
A mouse study at Memorial Sloan Kettering Cancer Center has found that adding Nef, a protein from HIV, allows donor CAR T cells to avoid detection by the immune system while still attacking tumors.
Rosuvastatin has possible interactions with alcohol, some other drugs, and certain supplements. Examples include antacids ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results